Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 60 entries
View as:

Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02526771 Org: User:
Start: 08/31/15 End: 12/31/17 Due: 12/31/18

Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00820157 Org: User:
Start: 11/30/08 End: 12/31/12 Due: 12/31/13

Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1

Phase: N/A Priority: Normal
NCT ID: NCT02724358 Org: User:
Start: 12/31/12 End: 12/31/15 Due: 12/31/16

Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT00817895 Org: User:
Start: 12/31/08 End: 12/31/10 Due: 12/31/11

Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03515369 Org: User:
Start: 05/31/18 End: 06/30/22 Due: 06/30/23

A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder

Phase: N/A Priority: Normal
NCT ID: NCT05668871 Org: User:
Start: 01/01/23 End: 11/30/24 Due: 11/30/25

Standard Treatments of Very-early Stage Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02728193 Org: User:
Start: 12/31/12 End: 12/31/15 Due: 12/31/16

Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Phase: N/A Priority: Normal
NCT ID: NCT02724475 Org: User:
Start: 12/31/12 End: 12/31/15 Due: 12/31/16

Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06530823 Org: User:
Start: 08/01/24 End: 08/01/28 Due: 08/01/29

Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

Phase: N/A Priority: Normal
NCT ID: NCT02724332 Org: User:
Start: 11/30/12 End: 12/31/15 Due: 12/31/16

Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06818773 Org: User:
Start: 02/28/25 End: 12/31/27 Due: 12/31/28

A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection

Phase: N/A Priority: Normal
NCT ID: NCT00819650 Org: User:
Start: 12/31/08 End: 12/31/10 Due: 12/31/11

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00849264 Org: User:
Start: 12/31/08 End: 12/31/10 Due: 12/31/11

QL1706 Combined with Lenvatinib and GEMOX As First - Line Treatment for Unresectable Biliary Tract Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06892925 Org: User:
Start: 05/31/25 End: 04/30/29 Due: 04/30/30

Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05540925 Org: User:
Start: 01/01/22 End: 09/01/22 Due: 09/01/23

Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology

Phase: N/A Priority: Normal
NCT ID: NCT02727673 Org: User:
Start: 12/31/12 End: 12/31/14 Due: 12/31/15

Postoperative Adjuvant TACE Treatment in CK18 Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT02724345 Org: User:
Start: 01/31/13 End: 12/31/15 Due: 12/31/16

Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH

Phase: N/A Priority: Normal
NCT ID: NCT02587884 Org: User:
Start: - End: 12/31/17 Due: 12/31/18

Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT02168608 Org: User:
Start: 09/30/14 End: 06/30/16 Due: 06/30/17

Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI

Phase: N/A Priority: Normal
NCT ID: NCT04891874 Org: User:
Start: 08/01/15 End: 12/31/20 Due: 12/31/21

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02150317 Org: User:
Start: 01/31/14 End: 12/31/16 Due: 12/31/17

Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC

Phase: N/A Priority: Normal
NCT ID: NCT06013943 Org: User:
Start: 03/17/23 End: 12/31/25 Due: 12/31/26

Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels

Phase: N/A Priority: Normal
NCT ID: NCT00814242 Org: User:
Start: 12/31/08 End: 11/30/11 Due: 11/30/12

The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02525965 Org: User:
Start: 08/31/15 End: 12/31/17 Due: 12/31/18

Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System

Phase: N/A Priority: Normal
NCT ID: NCT02525952 Org: User:
Start: 10/31/15 End: 12/31/17 Due: 12/31/18